Lowered serum dipeptidyl peptidase IV activity in patients with anorexia and bulimia nervosa

European Archives of Psychiatry and Clinical Neuroscience

Volumn 250, Issue 2, 2000, Pages 86-92

  Van West, Dirk ^a   Monteleone, Palmiero ^e   Di Lieto, Antonello ^e   De Meester, Ingrid ^b   Durinx, Christine ^b   Scharpe, Simon ^b   Lin, Aihua ^a   Maj, Mario ^e   Maes, Michael ^a,c,d  

^a Clinical Research Center for Mental Health of Antwerp   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e NONE

Author keywords

Anorexia; Bulimia; Dipeptidyl peptidase IV; Neuropeptides; Peptidases

Indexed keywords

DIPEPTIDYL PEPTIDASE IV;

ADULT; ANOREXIA NERVOSA; ARTICLE; BULIMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; PRIORITY JOURNAL; RATING SCALE;

EID: 0034070140     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004060070040     Document Type: Article

References (82)

1. Allende LM, Corell A, Manzanares J, Madruga D, Marcos A, Madrono A, et al (1998) Immunodeficiency associated with anorexia nervosa is secondary and improves after refeeding. Immunol 94:543-551
2. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Press, Washington DC
3. Andreasen NC, Endicott J, Spitzer RL, et al. (1977) The family history method using diagnostic criteria: reliability anf validity. Arch Gen Psychiatry 34:1229-1235
4. Ansorge S, Schon E (1987) Dipeptidyl peptidase IV (DPP IV), a functional marker of the T lymphocyte system. Acta Histochem 82:41-46
5. Armstrong-Esther CA, Lancey JH, Crisp AH, Bryant TN (1978) An investigation of the immune response of patients suffering from anorexia nervosa. Postgrad Med J 54:395-399
6. Barton RW, Prendergast J, Kennedy CA (1990) Binding of the T cell activation monoclonal antibody TA1 to dipeptidyl peptidase IV. J Leukocyte Biol 48:291-296
7. Bernstein HG, Schon E, Ansorge S, Rose I, Dorn A (1987) Immunolocalization of dipeptidyl aminopeptidase (DAP IV) in the developing human brain. Int J Dev Neurosci 5:237-242
8. Berrettinini WH, Kaye WH, Gwirtsman H, Allbright A (1988) Cerebrospinal fluid peptide YY immunoreactivity in eating disorders. Neuropsychobiol 19:121-4
9. Bessler H, Karp L, Notti I, Apter A, Tyano S, Djaldetti M, et al. (1993) Cytokine production in anorexia nervosa. Clin Neuropharmacol 3:237-243
10. Brambilla F, Bellodi L, Brunetta M, Perna G (1998) Plasma concentration of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha in anorexia and bulimia nervosa. Psychoneuroendocrinol 23:439-447
11. Cason J, Ainly CC, Wolstencraft RA, Norton KR, Thompson PH (1986) Cell mediated immunity in anorexia nervosa. Clin Exp Immunol 64:370-375
12. Catzeflis C, Pierroz DD, Rohner-Jeanrenaud F, Rivier JE, Sizonenki PC, Aubert ML (1993) Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats. Endocrinol 132:224-234
13. Conlon JM, Sheehan L (1983) Conversion of substance P to C-terminal fragments in human plasma. Regulatory Peptides 7: 335-345
14. De Meester I (1992) Characterization of human lymphocytic dipeptidyl peptidase IV and its identification as the activation antigen CD 26. Ph.D thesis. University of Antwerp, Belgium
15. De Meester I, Mertens AV, De Clerck LS, Scharpé S, Bridts CH, Stevens WJ (1993) Correlations between dipeptidyl peptidase IV and disease activity of rheumatoid arthritis (RA). J Allergy Clin Immunol 91:228-232
16. De Meester I, Korom S, Van Damme J, Scharpe S (1999) CD26, let it cut or cut it down. Immunol Today 20:367-375
17. Do Carmo I, Palma-Carlos ML, Melo A, Jorge Z, Macedo A, Nunes S, et al (1997) Characterization of leukocytes, lymphocytes and lymphocyte subsets in eating disorders. Allergie Immunol 29:261-268
18. Duke-Cohan JS, Morimoto C, Rocker JA, Schlossman SF (1995) A novel form of dipeptidyl peptidase IV found in human serum: isolation, characterization, and comparison with T lymphocyte membrane dipeptidyl peptidase IV (CD26). J Biol Chem 270:14 107-14 114
19. Fink S, Eckert E, Mitchell J, Crosby R, Pomeroy C (1996) T-lymphocyte subsets in patients with abnormal body weight: longitudinal studies in anaorexia nervosa and obesity. Int J Eating Disorders 20:295-305
20. Frohman L, Downs T, Heimer E, Felix A (1989) Dipeptidyl peptidase IV and trypsin-like enzymatic degradation of human growth hormone releasing hormone in plasma. J Clin Invest 83 :1533-1540
21. Fujita K, Hirano M, Ochiai J, et al (1978) Serum glycylproline p-nitroanilidase activity in rheumatoid arthritis and systemic lupus erythematosus. Clin Chem Acta 88:15-20
22. Garner DM, Olmstead MP, Polivy J (1983) Development and validation of a multidimensional eating disorder inventory for anorexia nervosa and bulimia. Int. J Eating Disorders 2:15-34
23. Gianotti L, Rolla M, Arvat E, Belliti D, Valetto MR, Ferdeghini M, et al (1999) Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa. Biol Psychiatry 45:334-339
24. Grimble RF (1989) Cytokines: their relevance to nutrition. Eur J Clin Nutr 43:217-230
25. Hagan MM, Moss DE (1995) Effect of peptide YY (PYY) on food-associated conflict. Physiol Behav 58:731-735
26. Hagan MM, Castaneda E, Sumaya IC, Fleming SM, Galloway J, Moss DE (1998) The effect of hypothalamic peptide YY on hippocampal acetylcholine release in vivo implications for limbic function in binge-eating behavior. Brain Res 805:20-28
27. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-61
28. Henderson M, Freeman CP (1987) A self-rating scale for bulimia: The 'BITE'. Br J Psychiatry 150:18-24
29. Herzog DB (1984) Are anorexic and bulimic patients depressed? Am J Psychiatry 141:1594-1597
30. Heymann E, Mentlein R (1978) Liver dipeptidyl aminopeptidase IV hydrolyzes substance P. FEBS Lett 91:360-364
31. Holden RJ, Pakula IS (1996) The role of tumor necrosis factor-alpa in the pathogenesis of anorexia and bulimia nervosa, cancer cachexia and obesity. Med Hypotheses 47:423-438
32. Hopsu-Havu VK, Glenner GG (1966) A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-β-naphthylamide. Histochem 7:197-201
33. Iwaki-Egawa S, Watanabe Y, Fujimoto Y (1995) Is CD26/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain. Immunobiol 194:429-442
34. Kasahara Y, Leroux-Roels G, Nakamura R, Chisari F (1984) Glycylprolyl-diaminopeptidase in human leukocytes: selective occurrence in T lymphocytes and influence on the total serum enzyme activity. Clin Chem Acta 139:295-302
35. Kato T, Nagatsu T, Fukasawa K, Harada M (1978) Successive cleavage of N-terminal Arg-Pro and Lys-Pro from substance P but no release of Arg-Pro from bradykinin, by X-Pro dipeptidyl-aminopeptidase. Biochim Biophys Acta 525:417-422
36. Kaye WH, Berrettini W, Gwirtsman H, George DT (1990) Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa. Arch Gen Psychiatry 47:548-556
37. Kehlen A, Gohring B, Langner J, Riemann D (1998) Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD 26 in renal carcinoma cells and renal tubular epitelial cells by cytokines and cAMP-increasing mediators. Clin Exp Immunol 111:435-441
38. Kiriki N, Nishiwaki S, Izumiya Y, Maeda Y, Kawakita Y (1987) Thyrotropin, prolactin, and growth hormone responses to thyrotropin-releasing hormone in anorexia nervosa and bulimia. Biol Psychiatry 22:167-176
39. Laessle RG, Schweiger U, Pirke KM (1988) Depression as a correlate of starvation in patients with eating disorders. Biol Psychiatry 23:719-725
40. Levy AB (1989) Neuroendocrine profile in bulimia nervosa. Biol Psychiatry 25:98-109
41. McMurray DN, Watson RR, Reyes MA (1981) Effects of renutrition on humoral and cell-mediated immunity in severely malnourished children. Am J Clin Nutr 34:2117-2121
42. Maeda K, Tanimoto K, Chihara K (1987) Abnormal growth hormone release following luteinizing hormone releasing hormone in anorexia nervosa. Japanese J Psychiatry Neurol 41:41-45
43. Maes M, De Meester I, Van Hoof G, Scharpé S, Bosmans E, Vandervorst C, et al (1991) Decreased serum dipeptidyl peptidase IV activity in major depression. Biol Psychiatry 30:577-586
44. Maes M, Scharpé S, De Meester I, Goossens F, Wauters A, Neels H, et al (1994) Components of biological variation in plasma prolyl endopeptidase and dipeptidyl peptidase activity in healthy man. Clin Chem 40:1686-1691
45. Maes M, Scharpé S, Meltzer HY, Calabrese J (1996) Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs. Acta Psychiatr Scand 93:1-8
46. Maes M, De Meester I, Verkerk R, Demendts P, Wauters A, Van Hoof G, et al (1997) Dipeptidyl peptidase serum activity in treatment resistant depression: relationships with immune-inflammatory markers. Psychoneuroendocrinol 22:65-78
47. Marcos A, Varela P, Toto O, Nova E. Lopez-Vidriero I, Morande G (1997) Evaluation of nutritional status by immunological assessment in bulimia nervosa: influence of body mass index and vomiting episodes. Am J Clin Nutr 66:4918-4978
48. Marsh DJ, Hollopeter G, Kafer KE. Palmiter RD (1998) Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat Med 4:718-721
49. Mattern T, Scholz W, Feller AC, Flad HD, Ulmer AJ (1991) Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocytes. Scand J Immunol 33:737-748
50. Mentlein R, Dahms P, Grandt D, Kruger R (1993) Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regulatory Peptides 49:133-144
51. Morimoto C, Schlossman SF (1998) The structure and function of CD26 in the T-cell immune response. Immunol Rev 161:55-70
52. Muller EE, Rolla M (1996) Aspects of the neuroendocrine control of somatotropic function in calorically restricted dogs and patients with eating disorders: studies with cholinergic drugs. Psychiatry Res 62:51-63
53. Mustafa A, Ward A, Treasure J, Peakman M (1997) T lymphocyte subpopulations in anorexia nervosa and refeeding. Clin Immunol Immunopathol 82:282-289
54. Nagatsu T, Hino M, Fuyamada H, Hayakawa T, Sakibara S, Nakagawa Y, et al (1976) New chromogenic substrates for x-prolyl dipeptidyl-aminopeptidase. Anal Biochem 74:466-476
55. Pirke KM, Nerl C, Krieg JC, Fichter MM (1992) Anorexia and bulimia nervosa. Int J Eating Disorders 2:185-189
56. Pirke KM, Broocks A, Wilckens T, Marquard R, Schweiger U (1993) Starvation-induced hyperactivity in the rat: the role of endocrine and neurotransmitter changes. Neurosci Biobehav Rev 17:287-294
57. Polack E, Nahmod VE, Emeric-Sauval E, Bello M, Costas M, Finkielman S, et al (1993) Low lymphocyte interferon-gamma production and variable proliferative response in anorexia nervosa patients. J Clin Immunol 13:445-451
58. Pomeroy C, Eckert E, Hu S, Eiken B, Mentink M, Crosby RD, et al (1994) Role of interleukin-6 and transforming growth factor-β in anorexia nervosa. Biol Psychiatry 36:836-839
59. Reinhold D, Wrenger S, Bank U, Buhling F, Hoffman T, Neubert K, et al (1996) CD26 mediates the action of HIV-1 Tat protein on DNA synthesis and cytokine production in U937 cells. Immunobiol 195:119-128
60. Riemann D, Kehlen A, Langner J (1995) Stimulation of the expression and the enzyme activity of aminopeptidase N/CD 13 and dipeptidylpeptidase IV/CD 26 on human renal cell carcinoma cells and renal tubular epithelial cells by T cell-derived cytokines, such as IL-4 and IL-13. Clin Exp Immunol 100: 277-283
61. Ruffin MP, Even PC, El-Ghissassi M, Nicolaidis S (1997) Metabolic action of neuropeptide Y in relation to its effect on feeding. Physiol Behav 62:1259-1264
62. Ruscetti FW, Palladino MA (1991) Transforming growth factor-β and the immune system. Prog Growth Factor Res 3:159-175
63. Scharpé S, De Meester I, Van Hoof G, Hendriks D, Uyttenbroeck W, Ntakarutimana V, et al (1990) Serum DPP IV activity in transplant recipients. Clin Chem 36:984
64. Schattner A, Steinbock M, Tepper R, Schonfeld A, Vaisman N, Hahn T (1990a) Tumor necrosis factor production and cell-mediated immunity in anorexia nervosa. Clin Exp Immunol 76: 62-66
65. Schattner A, Tepper R, Steinbock M, Hahn T, Schoenfeld A (1990 b) TNF, interferon-gamma and cell-mediated cytotoxicity in anorexia nervosa; effect of refeeding. J Clin Laboratory Immunol 32:183-184
66. Schattner A, Tepper R, Steinbock M, Schoenfeld A, Vaisman N, Hahn T (1992) Cytokines in anorexia nervosa: nutritional or neuroimmunal changes? Harefuah 123:245-247
67. Schmitz T, Underwood R, Khiroya R, Bachovchin W, Huber B (1996) Potentiation of the immune response in HIV-1+ individuals. J Clin Invest 97:1545-1549
68. Scholz W, Mentlein R, Heymann E, Feller AC, Ulmer AJ, Flad HD (1985) Interleukin 2 production by human T lymphocytes identified by antibodies to dipeptidyl peptidase IV. Cell Immunol 93:199-211
69. Schon E, Demuth HU, Eichmann E, Horst HJ, Korner IJ, Kopp J, et al (1989) Dipeptidyl peptidase IV in human T lymphocytes. Scand J Immunol 29:127-132
70. Sporn MB, Robert AB (1989) Transforming growth factor-β. Multiple actions and potential clinical applications. JAMA 262: 938-941
71. Staurenghi AH, Masera RG, Prolo P, Griot G, Sartori ML, Ravizza L, et al (1997) Hypothalamic-pituitary-adrenal axis function, psychopathological traits, and natural killer (NK) cell activity in anorexia nervosa. Psychoneuroendocrinol 22:575-590
72. Tanaka T, Duke-Cohan JS, Kameoka J, Yaron A, Lee I, Schlossman SF, et al (1994) Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proceed Nat Acad Sci USA 91:3082-3086
73. Travaglini P, Beck-Peccoz P, Ferrari C, Ambrosi B, Paracchi A, Severgnini A, et al (1976) Some aspects of hypothalamic-pituitary function in patients with anorexia nervosa. Acta Endocrinol 81:252-262
74. Vaccarino FJ, Kennedy SH, Ralevski E, Black R (1994) The effects of growth hormone-releasing factor on food consumption in anorexia nervosa patients and normals. Biol Psychiatry 35: 446-451
75. Vaisman N, Hahn T, Dayan Y, Schattner A (1990) The effect of different nutritional states on cell-mediated cytotoxicity. Immunol Lett 24:37-41
76. Vaisman N, Hahn T (1991) Tumor necrosis factor-alpha and anorexia: cause or effect? Metabolism: Clin Exp 40:720-723
77. Van Hoof G, De Meester I, van Sande M, Scharpé S, Yaron A (1992) Distribution of prolin-specific aminopeptidases in human tissues and body fluids. Eur J Clin Chem Clin Biochem 30: 333-338
78. Van Hoof G, Goossens F, De Meester I, Hendriks D, Scharpé S (1995) Proline motifs in peptides and their biological processing. FASEB J 9:736-744
79. Vassalli P (1992) The pathophysiology of tumor necrosis factors. Ann Rev Immunol 10:411-452
80. World Health Organization (1987) Composite International Diagnostic Interview. WHO, Geneva
81. Yaron A, Naider F (1993) Prolin-dependent structural and biological properties of peptides and proteins. Crit Rev Biochem Molecul Biol 28:31-81
82. Zukowska-Grojec Z (1997) Neuropeptide Y: implications in vascular remodeling and novel therapeutics. Drugs News Perspect 10:587-595